CollPlant Patent Granted in U.S. for Photocurable Dermal Filler

 CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant's photocurable dermal filler product candidate, being developed for the aesthetics market.

https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-patent-granted-in-us-for-photocurable-dermal-filler-301974032.html